Volume 56, Issue 2, Pages (August 1999)

Slides:

Advertisements

Similar presentations

Kamyar Kalantar-Zadeh Kidney International

Advertisements

A skeptical view of assisted home peritoneal dialysis

Volume 59, Issue 2, Pages (February 2001)

Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory.

Volume 62, Issue 2, Pages (August 2002)

Volume 55, Issue 4, Pages (April 1999)

Use of hemodialysis and hemoperfusion in poisoned patients

Marlies Noordzij, Kitty J. Jager Kidney International

End-stage renal disease in developing countries

Volume 64, Issue 6, Pages (December 2003)

Long-term follow-up of patients randomized to biocompatible or conventional peritoneal dialysis solutions show no difference in peritonitis or technique.

Confounding: What it is and how to deal with it

Volume 72, Issue 8, Pages (October 2007)

Volume 60, Issue 2, Pages (August 2001)

Continuous renal replacement therapy in the critically ill patient

Mortality caused by sepsis in patients with end-stage renal disease compared with the general population Mark J. Sarnak, Bertrand L. Jaber Kidney International

Section 5: Dialysis Interventions for Treatment of AKI

Haiyan Wang, Luxia Zhang, Jicheng Lv Kidney International

Francesco Paolo Schena Kidney International

Kamyar Kalantar-Zadeh Kidney International

Steroid-free maintenance immunosuppression in kidney transplantation: is it time to consider it as a standard therapy? Fu L. Luan, Diane E. Steffick,

Volume 80, Issue 9, Pages (November 2011)

Comorbidity and confounding in end-stage renal disease

A new era in phosphate binder therapy: What are the options?

Early mortality in dialysis and adequacy of predialysis renal care: the picture is more complex than we thought Nicolas Rognant, Maurice Laville Kidney.

Volume 80, Issue 10, Pages (November 2011)

Volume 67, Issue 4, Pages (April 2005)

Volume 77, Issue 2, Pages (January 2010)

Late referral and modality choice in end-stage renal disease

Volume 74, Issue 8, Pages (October 2008)

The analysis of survival data: the Kaplan–Meier method

Acute myocardial infarction in patients with end-stage renal disease

Body size and outcomes on peritoneal dialysis in the United States

Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory.

Volume 58, Issue 2, Pages (August 2000)

Volume 68, Issue 5, Pages (November 2005)

Volume 76, Issue 6, Pages (September 2009)

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Elevated risk of stroke among patients with end-stage renal disease

Cardiovascular disease in pediatric chronic dialysis patients

Environmental exposure to lead and progressive diabetic nephropathy in patients with type II diabetes J.-L. Lin, D.-T. Lin-Tan, C.-C. Yu, Y.-J. Li, Y.-Y.

Lynda Anne Szczech, Ira L. Lazar Kidney International

A skeptical view of assisted home peritoneal dialysis

Quality of life in peritoneal dialysis patients: Decline over time and association with clinical outcomes Sr. Anne B. Bakewell, Rob M. Higgins, Mair.

Volume 86, Issue 1, Pages (July 2014)

Volume 72, Issue 4, Pages (August 2007)

Volume 54, Issue 2, Pages (August 1998)

Racial differences in survival of patients on dialysis

The valuable contribution of observational studies to nephrology

Organ transplantation goes to the movies

Volume 72, Issue 2, Pages (July 2007)

Does equal care give equal outcomes?

The Iranian model of living renal transplantation

Volume 62, Issue 2, Pages (August 2002)

The Danish Renal Biopsy Register

Charles A. Herzog Kidney International

Is complement a target for therapy in renal disease?

Bradley A. Warady, Mwaffek Bashir, Lynn A. Donaldson

Renal replacement therapy in Latin America

Volume 70, Issue 5, Pages (September 2006)

Douglas E. Schaubel, Howard I. Morrison, Stanley S.A. Fenton

Volume 59, Issue 2, Pages (February 2001)

Volume 70, Issue 10, Pages (November 2006)

The International Pediatric Peritonitis Registry: Starting to walk

Volume 57, Issue 2, Pages (October 2000)

Survival of propensity matched incident peritoneal and hemodialysis patients in a United States health care system Victoria A. Kumar, Margo A. Sidell,

Mary B. Leonard, Lynn A. Donaldson, Martin Ho, Denis F. Geary

E.F. Vonesh, J.J. Snyder, R.N. Foley, A.J. Collins

Volume 68, Issue 3, Pages (September 2005)

Presentation transcript:

Volume 56, Issue 2, Pages 720-728 (August 1999) Quality of life over time in dialysis: The Netherlands Cooperative Study on the Adequacy of Dialysis1 Maruschka P. Merkus, Kitty J. Jager, Friedo W. Dekker, Rob J. de Haan, Els W. Boeschoten, Raymond T. Krediet Kidney International Volume 56, Issue 2, Pages 720-728 (August 1999) DOI: 10.1046/j.1523-1755.1999.00563.x Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 1 Change over time in physical and mental summary quality of life (QL) according to the stay on mode of renal replacement therapy (means ±se). QL values are normalized to a general population mean of 50 and a standard deviation of 10 (that is, a T-score metric, as discussed in the Methods section). Symbols are: (▪) stay on PD; (•) stay on HD; (▿) dialysis switchers; (○) transplanted; (⋄) deceased. Kidney International 1999 56, 720-728DOI: (10.1046/j.1523-1755.1999.00563.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 2 Change over time in physical and mental summary quality of life (QL) of the stay on HD (•) and the stay on PD (▪) patients adjusted for the baseline value of QL and comorbid status (means ±se). QL values are normalized to a general population mean of 50 and a standard deviation of 10 (that is, a T-score metric, as discussed in the Methods section). Kidney International 1999 56, 720-728DOI: (10.1046/j.1523-1755.1999.00563.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 3 Change over time in the physical and mental summary quality of life (QL) according to the initial dialysis modality (that is, intention-to-treat analysis) adjusted for the baseline value of QL and comorbid status (means ±se). QL values are normalized to a general population mean of 50 and a standard deviation of 10 (that is, a T-score metric, as discussed in the Methods section). Symbols are: (•) intention to treat HD; (▪) intention to treat PD. Kidney International 1999 56, 720-728DOI: (10.1046/j.1523-1755.1999.00563.x) Copyright © 1999 International Society of Nephrology Terms and Conditions